Tag: NCT02956226
-
Cannabinoids for Behavioral Problems in Autism Spectrum Disorder: A Double Blind, Randomized, Placebo-controlled Trial With Crossover.
https://clinicaltrials.gov/ct2/show/NCT02956226 Study Description Go to Brief Summary: This study aims to assess the safety, tolerability and efficacy of cannabinoids mix [cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) in a 20:1 ratio, BOL Pharma, Israel] for behavioral problems in children and youth with ASD. Condition or disease Intervention/treatment Phase Autistic Disorder Drug: Cannabinoids – 99% pure cannabinoids mixDrug: PlaceboDrug: Cannabinoids…
WeedPress: The Paper Trail 